Ivi Valencia S.L.

At Ivi Valencia S.L., clinical research is centered on Female Urogenital Diseases and Pregnancy Complications, with a strong focus on reproductive medicine and treatment support for women pursuing fertility care.

• Studies in female infertility and assisted reproductive technologies aim to better understand how to support women undergoing fertility treatment.
• Research involving women with an indication for IVF or ICSI is exploring ways to improve outcomes in in vitro fertilization-based care.
• Trials are assessing endometrial function, including how different forms of progesterone may influence uterine preparation and reproductive success.

The site is also evaluating treatments that may affect ovarian stimulation and uterine contractility, with the broader goal of improving fertility treatment effectiveness and understanding how the reproductive system responds to key therapies.

Research at this hospital/clinic in Valencia is focused on improving the care of women undergoing fertility treatment, especially those receiving ART and related reproductive interventions.

• Work on female infertility is examining how reproductive treatments can be refined to better support patient outcomes.
• Trials in women undergoing IVF or ICSI are helping assess approaches intended to improve treatment response and clinical effectiveness.
• Studies of progesterone use are looking at its role in preparing the endometrium for implantation.

Additional investigations are testing how fertility-related therapies influence uterine activity and hormone-related responses, contributing to a clearer picture of reproductive health care.

The clinical trial portfolio at Ivi Valencia S.L. includes research into how the endometrium and ovaries respond during fertility treatment, especially in the setting of controlled ovarian stimulation.

• Investigations of exogenous progesterone are focused on endometrial structure and function.
• Studies combining fertility medicines are evaluating whether treatment timing and pairing can improve reproductive outcomes.
• Research on uterine contractility is helping clarify how the uterus behaves during treatment cycles.

Together, these trials are designed to support better understanding of implantation conditions and the effectiveness of fertility-focused therapies.

This site’s Medicina Reproductiva department is conducting a small but focused set of trials aimed at improving care for women who need assisted reproductive technologies.

• Female infertility remains a key disease area, with studies looking at ways to enhance treatment support.
• Research in women undergoing IVF/ICSI is examining how fertility therapies can be used more effectively.
• Trials are also exploring the biological effects of medications used during ovarian stimulation and uterine preparation.

The overall research effort is aimed at improving reproductive outcomes by studying how the body responds to treatments commonly used in fertility care.